NCT00560612View on ClinicalTrials.gov

Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Stress Disorders, Post-Traumatic
Interventions
DRUG

Paroxetine

Paroxetine 10 mg-40 mg or placebo; flexible dosing; 12-week duration.

DRUG

Placebo

Placebo: same as paroxetine (active comparator)

Trial Locations (1)

27705

Durham VAMC, Durham

Sponsors
All Listed Sponsors
lead

Durham VA Medical Center

FED